| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 09/29/2023 | Magenta Therapeutics, Inc. | MGTA | Purchase | Common Stock | 24.7k | $13.63 | $336.3k | See footnote | 09/29/2023 |
| 09/26/2023 | Magenta Therapeutics, Inc. | MGTA | Purchase | Common Stock | 30k | $13.15 | $394.5k | See footnote | 09/26/2023 |
| 07/13/2023 | Apogee Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 47.8k | $17.00 | $811.9k | | 07/13/2023 |
| 07/13/2023 | Apogee Therapeutics, Inc. | | Purchase | Common Stock | 892.5k | $17.00 | $15.2M | By Fairmount Healthcare Co-Invest II LP | 07/13/2023 |
| 07/13/2023 | Apogee Therapeutics, Inc. | | Purchase | Common Stock | 2M | $17.00 | $33.9M | By Fairmount Healthcare Fund II LP | 07/13/2023 |
| 07/13/2023 | Apogee Therapeutics, Inc. | | Purchase | Common Stock | 55.9k | $17.00 | $950.5k | By Fairmount Healthcare Fund LP | 07/13/2023 |
| 08/17/2022 | Viridian Therapeutics, Inc.\DE | MGEN | Purchase | Common Stock | 425.5k | $23.50 | $10M | Fairmount Healthcare Fund II LP | 08/17/2022 |
| 09/21/2021 | Viridian Therapeutics, Inc.\DE | MGEN | Purchase | Common Stock | 909k | $11.00 | $10M | Fairmount Healthcare Fund II LP | 09/21/2021 |
| 10/30/2020 | Viridian Therapeutics, Inc.\DE | MGEN | Purchase | Series A Non-Voting Convertible Preferred Stock | 5.5k | $465.96 | $2.6M | Fairmount Healthcare Fund LP | 10/30/2020 |
| 10/30/2020 | Viridian Therapeutics, Inc.\DE | MGEN | Purchase | Series A Non-Voting Convertible Preferred Stock | 28.8k | $465.96 | $13.4M | Fairmount Healthcare Fund II LP | 10/30/2020 |
| 10/27/2020 | Viridian Therapeutics, Inc.\DE | MGEN | Other (acquisition) | Common Stock | 87.9k | $0.00 | $0 | Fairmount Healthcare Fund LP | 10/27/2020 |
| 10/27/2020 | Viridian Therapeutics, Inc.\DE | MGEN | Other (acquisition) | Common Stock | 438.5k | $0.00 | $0 | Fairmount Healthcare Fund II LP | 10/27/2020 |
| 10/27/2020 | Viridian Therapeutics, Inc.\DE | MGEN | Other (acquisition) | Series A Non-Voting Convertible Preferred Stock | 16.5k | $0.00 | $0 | Fairmount Healthcare Fund LP | 10/27/2020 |
| 10/27/2020 | Viridian Therapeutics, Inc.\DE | MGEN | Other (acquisition) | Series A Non-Voting Convertible Preferred Stock | 82.3k | $0.00 | $0 | Fairmount Healthcare Fund II LP | 10/27/2020 |